See more : Themis Medicare Limited (THEMISMED.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PT Teladan Prima Agro Tbk (TLDN.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Teladan Prima Agro Tbk, a leading company in the Agricultural Farm Products industry within the Consumer Defensive sector.
- Malachite Innovations, Inc. (VBIO) Income Statement Analysis – Financial Results
- Serma Group Société anonyme (ALSER.PA) Income Statement Analysis – Financial Results
- Nippon BS Broadcasting Corporation (9414.T) Income Statement Analysis – Financial Results
- Alvarion Ltd. (ALVRQ) Income Statement Analysis – Financial Results
- China Southern Airlines Company Limited (600029.SS) Income Statement Analysis – Financial Results
PT Teladan Prima Agro Tbk (TLDN.JK)
About PT Teladan Prima Agro Tbk
PT Teladan Prima Agro Tbk, together with its subsidiaries, engages in managing palm oil plantations, mills, and renewable energy. It manages and cultivates 60,468 hectares of oil palm plantations in the East Kalimantan Province; and transforms the fresh fruit bunches collected from its nucleus and plasma oil palm plantations into crude palm oil and palm kernel. The company also generates renewable power utilizing its palm oil waste to third-party consumers. PT Teladan Prima Agro Tbk was founded in 2004 and is headquartered in South Jakarta, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3,995.57B | 3,613.18B | 2,938.38B | 2,715.71B | 2,082.93B | 1,930.49B |
| Cost of Revenue | 2,953.35B | 2,366.65B | 1,762.18B | 1,949.90B | 1,661.35B | 1,390.33B |
| Gross Profit | 1,042.22B | 1,246.52B | 1,176.20B | 765.81B | 421.58B | 540.16B |
| Gross Profit Ratio | 26.08% | 34.50% | 40.03% | 28.20% | 20.24% | 27.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 67.24B | 43.12B | 59.60B | 39.36B | 49.97B | 53.81B |
| Selling & Marketing | 203.65B | 156.99B | 122.38B | 169.77B | 199.40B | 172.73B |
| SG&A | 400.16B | 200.11B | 181.98B | 209.13B | 249.38B | 226.55B |
| Other Expenses | 0.00 | 209.25B | 67.92B | 6.53B | 67.12B | 27.00M |
| Operating Expenses | 400.16B | 409.36B | 249.90B | 215.66B | 316.50B | 382.55B |
| Cost & Expenses | 3,353.51B | 2,776.01B | 2,012.08B | 2,165.56B | 1,977.85B | 1,772.88B |
| Interest Income | 18.66B | 13.06B | 21.08B | 9.86B | 6.93B | 25.17B |
| Interest Expense | 107.54B | 140.61B | 213.29B | 248.35B | 286.50B | 318.59B |
| Depreciation & Amortization | 16.58B | 311.26B | 324.72B | 323.48B | 322.58B | 325.54B |
| EBITDA | 743.28B | 1,159.98B | 1,276.20B | 888.76B | 333.63B | 498.98B |
| EBITDA Ratio | 18.60% | 23.93% | 30.56% | 20.99% | 5.34% | 9.42% |
| Operating Income | 642.06B | 835.66B | 934.95B | 556.16B | 104.42B | 149.12B |
| Operating Income Ratio | 16.07% | 23.13% | 31.82% | 20.48% | 5.01% | 7.72% |
| Total Other Income/Expenses | -20.91B | -129.82B | -264.06B | -245.04B | -386.69B | -302.05B |
| Income Before Tax | 621.15B | 705.84B | 670.89B | 311.12B | -282.27B | -152.93B |
| Income Before Tax Ratio | 15.55% | 19.54% | 22.83% | 11.46% | -13.55% | -7.92% |
| Income Tax Expense | 169.36B | 131.86B | 139.73B | 78.72B | -18.85B | 55.73B |
| Net Income | 451.79B | 573.97B | 524.26B | 232.40B | -263.42B | -208.66B |
| Net Income Ratio | 11.31% | 15.89% | 17.84% | 8.56% | -12.65% | -10.81% |
| EPS | 34.90 | 44.83 | 14.54 | 6.45 | -7.31 | -16.79 |
| EPS Diluted | 34.90 | 44.83 | 14.54 | 6.45 | -7.31 | -16.79 |
| Weighted Avg Shares Out | 12.95B | 12.80B | 36.05B | 36.05B | 36.05B | 12.43B |
| Weighted Avg Shares Out (Dil) | 12.95B | 12.80B | 36.05B | 36.05B | 36.05B | 12.43B |
Source: https://incomestatements.info
Category: Stock Reports